ABSTRACT

Psoriatic arthritis is a chronic inflammatory arthritis which affects about 5-25 percent of psoriasis patients. It can cause permanent joint damage and disability. Several studies have looked at the prevalence of PsA in countries worldwide. In the United States, the prevalence levels vary from 0.06 to 0.25 per cent. Estimates of prevalence in Europe range from 0.05 per cent in Turkey7 to 0.21 per cent in Sweden. There are only a few records of prevalence of PsA in South America and Asia, indicating a lower prevalence in those regions (0.07 per cent in Buenos Aires and 0.02 per cent in China). Psoriatic arthritis is easily diagnosed in typical skin lesions can, however, often occur in the absence of skin lesions using Psoriatic Arthritis Criteria Classification. Screening of psoriasis patients using a questionnaire can aid in early diagnosis. It has also been found that patients with PsA have very heterogeneous courses of disease. Nail dystrophy, lesions of the scalp and intergluteal / perianal psoriasis are associated with a greater chance of psoriatic arthritis developing. In general with the introduction of new medications, early diagnosis can lead to early care and a better outcome. In this review, current knowledge is discussed about risk factors of Psoriatic Arthritis, Laboratory findings for Psoriatic Arthritis, Demographic Features of PsA, screening & major clinical characteristics of Psoriatic Arthritis. Keywords: Psoriatic arthropathy, Demographic Features, Psoriasis arthritica, Risk Factors, Epidemiology, Screening tools
Publication date: 01/02/21

https://ijbpas.com/pdf/2021/February/MS_IJBPAS_2021_5348.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2021/10.2.5348